Shao C, Zhang S, Cheng Z, Yang K, et al. Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial. Atherosclerosis 2025;407:120408.
PMID: 40543299